Anti-Hypertension Drug Therapy Deck 2 Flashcards
(48 cards)
Beta blocker types
Cardio-Selective
Nonselective
Combined
Cardio-Selective example
atenolol, metoprolol
nonselective example
propranolol block B1 and B2
combined example
Carvedilol: blocks alpha 1 and beta 1 and beta 2
Labetalol: block alpha 1 and beta 1
beta blocker indication
Use to manage HTN in patients with: angina, tachyarrhythmias, MI, and glaucoma
beta blocker are not to be used as f
first line therapy, especially in patients over age 60
BB Action
Impedes the action of catecholamines at adrenergic receptors
Reduces heart rate
Reduces force of myocardial contraction
Reduces the velocity of impulse conduction through AV node
Reduces the automaticity of ectopic pacemakers
Reduces the release of renin in the kidneys
BB net effect
Net effect: decreased cardiac output, sympathetic outflow; reduce cardiac morbidity and mortality
BB SE
Side effects: may cause – bronchospasm, depression, bradyarrhythmia, insomnia, mask hypoglycemia
BB are
Lipid soluble, adjust dosage with advancing age
BB are bio transofred in the
Bio-transformed in the liver, rest eliminated in kidney
Metoprolol is easier
easier on kidneys than atenolol
BB Contraindications
Do not use in patients with a history of sick sinus syndrome, heart failure, or 2nd or 3rd degree AV block
BB precautions
not stop abruptly in patient with CVD
BB do not
not stop abruptly in patient with CVD
BB not specific recomend
Net effect: decreased cardiac output, sympathetic outflow; reduce cardiac morbidity and mortality
Supplemental Drug Classes
Centrally Acting Alpha2 Agonists
Peripherally Acting Adrenergic Antagonists
Direct-Acting Peripheral Vasodilators
Alpha 1 Receptor Blockers
Centrally Acting Alpha 2 Agonists example
Clonidine, methyldopa
Centrally Acting Alpha 2 Agonists MOA
Stimulates alpha 2 receptors in the brainstem
Subdues sympathetic outflow to heart, kidneys, and peripheral vasculature
Reduces renin activity
Centrally Acting Alpha 2 Agonists net effect
Not considered first line treatment except in Pregnancy (methyldopa)
Centrally Acting Alpha 2 Agonists not considered
Not considered first line treatment except in Pregnancy (methyldopa)
Centrally Acting Alpha 2 Agonists are
2nd or 3rd adjunct therapy.
Centrally Acting Alpha 2 Agonists often adminstered with a
diuretic because of tendency to cause fluid rention
Centrally Acting Alpha2 Agonists SE
Side effects: Na retention with weight gain, drowsiness, sedation, dizziness, orthostatic hypotension, restlessness and nervousness, depression, dry mouth